Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SPECTROBID

BACAMPICILLIN HYDROCHLORIDE

Standard Dose
125MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SPECTROBID is listed in Drugs@FDA under application 050556 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BACAMPICILLIN HYDROCHLORIDE Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor PFIZER Submission history Latest submission status date: 1982-03-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview SPECTROBID is listed in Drugs@FDA under application 050556 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BACAMPICILLIN HYDROCHLORIDE Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor PFIZER Submission history Latest submission status date: 1982-03-23 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.